APA citiranje

Mahajan, R. (2009). Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes. Medknow Publications.

Citação norma Chicago

Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.

MLA citiranje

Mahajan, Rajiv. Bromocriptine Mesylate: FDA-approved Novel Treatment for Type-2 Diabetes. Medknow Publications, 2009.

Opozorilo: Ti citati niso vedno 100% točni.